Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
507 Leser
Artikel bewerten:
(1)

North America Frac Sand Inc.: Voycare Announces Head of Product for Online Medical Second Opinion Portal

COVINA, CA / ACCESSWIRE / February 18, 2020 / North America Frac Sand, Inc. dba Voycare (OTC PINK:NAFS) ("NAFS" or "Voycare"), a California-based medical tourism and telemedicine service provider announces today the appointment of a Ellen Wu as the new Head of Product to oversee the development of the company's new Chinese language medical second opinion portal.

Wu has spent the last nine years working in product marketing, branding and design for multinational firms such as Deloitte, Saatchi & Saatchi and Blue Focus Communications. Her work experience in the U.S. and China, coupled with her studies in the U.K. makes her the ideal candidate to lead the development and go-to-market efforts for the company's upcoming second opinion portal.

"We are excited to welcome Ellen to our China based team," said Voycare COO Xuemei Li. "Her vision and impressive track record, clearly demonstrates her ability to develop and execute a product roadmap capable of taking our new telemedicine product to market. Her pulse on the China market will help us gain a front row seat to the evolving trends in the country that will help us better improve our product user experience, as well as develop key business partnerships on the ground."

The appointment of Wu to a senior level management position in China will help the company enter China's rapidly growing telemedicine industry, which is projected to be a 700 billion RMB or approximately $US100 billion market size by the end of 2020.

The secure online portal will allow users throughout China and other Mandarin speaking countries to seek second opinion medical evaluations from international doctors. After creating an account on the portal, users will be able to upload medical records in order to be translated into English and sent to overseas doctors for a secondary opinion.

Last week, the company announced their decision to fast track the launch of the portal in response to better facilitating those looking to continue overseas medical treatment or secondary opinions, without disruption by the current temporary travel restrictions from the ongoing Coronavirus outbreak in China.

For more information about Voycare, please visit, www.voycare.com or follow us on Twitter @nafsvoycare.

About Voycare

North America Frac Sand, Inc. (OTC: NAFS) dba Voycare (www.voycare.com) is a California based medical tourism and telemedicine service provider helping overseas patients gain access to quality health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery and wellness. Voycare's executive team has over 20 years of cross border tourism experience, specifically servicing Chinese outbound travelers to North and South America.

Safe Harbor Statement

This news release contains certain forward-looking information. All information, other than information regarding historic fact that addresses activities, events or developments that the Company believes, expects or anticipates will or may occur in the future is forward-looking information. The forward-looking information contained in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. The forward-looking information contained in this news release is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from current expectations. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable law, the Company disclaims any obligation to update or modify such forward-looking information, either because of new information, future events or for any other reason. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

Contact Information
Voycare

+1.626.784.5846
info@voycare.com
www.voycare.com

SOURCE: North America Frac. Sand Inc. / Voycare



View source version on accesswire.com:
https://www.accesswire.com/576795/Voycare-Announces-Head-of-Product-for-Online-Medical-Second-Opinion-Portal

© 2020 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.